CNTO 95, a monoclonal antibody against alpha v integrins, enhances the therapeutic efficacy of fractionated radiation therapy in vivo. Ning, S., Nemeth, J. A., Hanson, R. L., Forsythe, K., Knox, S. J. AMER ASSOC CANCER RESEARCH. 2007: 3537S–3537S

View details for Web of Science ID 000251969000621